New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments
New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments Findings from Spherix's fourth annual patient chart audit of more than 500 FSGS patients reveal not only a large unmet need in this market, but also optimism about the future – especially for […]